Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results
Dejan Orlic, MD*,
Erminio Bonizzoni, PhD ,
Goran Stankovic, MD*,
Flavio Airoldi, MD ,
Alaide Chieffo, MD ,
Nicola Corvaja, MD*,
Giuseppe Sangiorgi, MD*,
Massimo Ferraro, RN*,
Carlo Briguori, MD ,
Matteo Montorfano, MD ,
Mauro Carlino, MD and
Antonio Colombo, MD, FACC* ,*
* EMO, Centro Cuore Columbus Hospital, Milan, Italy
San Raffaele Hospital, Milan, Italy
Institute of Medical Statistics and Biometry, University of Milan, Milan, Italy

View larger version (13K):
[in a new window]
|
Figure 1 Kaplan-Meier estimates of the probability of survival without target lesion revascularization (TLR) (A), without target vessel revascularization (TVR) (B), and without cumulative total major adverse cardiac events (MACE) (C).
|
|
|